Advanced search
Start date
Betweenand

Cancer survival on the Northwest of São Paulo State, Brazil: a regional population-based study

Grant number: 19/21722-0
Support type:Scholarships abroad - Research Internship - Post-doctor
Effective date (Start): February 01, 2020
Effective date (End): January 31, 2021
Field of knowledge:Health Sciences - Collective Health - Epidemiology
Principal Investigator:José Humberto Tavares Guerreiro Fregnani
Grantee:Allini Mafra da Costa
Supervisor abroad: Isabelle Soerjomataram
Home Institution: Hospital do Câncer de Barretos. Fundação Pio XII (FP). Barretos , SP, Brazil
Local de pesquisa : International Agency for Research on Cancer (IARC), France  
Associated to the scholarship:18/22097-0 - Malignant neoplasms of the 18 cities of Barretos Regional Health District (RhD), Sao Paulo, Brazil: the importance of a population-based cancer registry, BP.PD

Abstract

Population studies using data of Population-Based Cancer Registries (PBCR) have often been used to infer hypotheses about the etiology of cancer, risk factors, and prognostic factors. Population-based cancer survival is a metric that can help evaluate whether all people had access to effective treatment services. The objective of this study is to establish surveillance of cancer survival and trends in survival over the 18-year period (2000-2017) among patients diagnosed with cancer in the region of Barretos (São Paulo state, Brazil). To estimate long-term survival patterns and trends, vital statistics of patients diagnosed with cancer during 2000-2017 were obtained from the PBCR-Barretos and life tables for registry's territory from the Official Federal Database. In cooperation with SEADE Foundation (Thematic project - FAPESP process: 2017/03787-2), PBCR-Barretos data were linked (deterministic linkage) with the database of death to update the last information about the patient. The study will include 15 type of cancers or groups of cancers: breast (only for women), cervix, colorectal, liver, lung, skin melanoma, oesophagus, ovary, pancreas, prostate, and stomach in adults (15-99 years); brain tumors, myeloid and lymphoid malignancies, and leukemias (all cases).